Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Oncology Institute Inc
NASDAQ:STLN
Oncology Institute Inc
NASDAQ:STLN
Price:
4.34
USD
8.5%
Market Closed
Market Cap:
$433.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Wall St Price Targets
STLN Price Forecast
Based on 7 analysts
Based on 7 analysts
+135% Upside
from
$4.34
today
Oncology Institute Inc (STLN)’s 12-month stock price forecast through November 2027 has a consensus target of $10.2, implying 135% upside. The forecast is based on price targets from 7 Wall Street analysts.
STLN Analyst Rating
Based on 4 analysts
Based on 4 analysts
Analysts rate STLN Strong buy, with 4 of 4 recommending Buy or Strong buy.
Oncology Institute Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is STLN's stock price target?
Price Target
10.2
USD
10.2
USD
According to Wall Street analysts, the average 1-year price target for STLN is 10.2 USD with a low forecast of 8.08 USD and a high forecast of 10.5 USD.
What is the Revenue forecast for Oncology Institute Inc?
Projected CAGR
32%
32%
Over the last 6 years, the compound annual growth rate for Revenue has been 22%. The projected CAGR for the next 3 years is 32%.
What is the Gross Profit forecast for Oncology Institute Inc?
Projected CAGR
40%
40%
Over the last 6 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 3 years is 40%.
